Drug Patents owned by Iceutica Operations
1. List of Vivlodex drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9526734 | ICEUTICA OPERATIONS | Formulation of meloxicam |
Mar, 2033
(9 years from now) | |
| US9808468 | ICEUTICA OPERATIONS | Formulation of meloxicam |
Mar, 2035
(11 years from now) | |
| US9649318 | ICEUTICA OPERATIONS | Formulation of meloxicam |
Mar, 2035
(11 years from now) | |
Do you want to check out VIVLODEX patents from before 2022?
Drugs and Companies using MELOXICAM ingredient
Market Authorisation Date: 22 October, 2015
Treatment: Management of osteoarthritis pain by administering 10 mg of meloxicam; Management of osteoarthritis pain by administering 5 mg of meloxicam
Dosage: CAPSULE;ORAL
How can I launch a generic of VIVLODEX before it's patent expiration?
More Information on Dosage
VIVLODEX family patents
8
United States
1
New Zealand
1
Korea, Republic of
1
Uruguay
1
China
1
Philippines
1
Brazil
1
Canada
1
South Africa
1
Singapore
1
Morocco
1
EA
1
Mexico
1
Japan
1
Australia
1
European Union
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic